Please login to the form below
New Accounts, July, 2006 - Advertising
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period April 2006 to June 2006 inclusive
The following tables list new pharmaceutical account wins notified to us by the winning agencies for the period April 2006 to June 2006 inclusive. Please note that inclusion in this table does not necessarily indicate exclusivity and other agencies may also be involved with some of the products listed in other ways, or in domestic, overseas or international markets. To submit an entry for New Accounts, email new_accounts@pmlive.com
|
|
|
|  |
|
Actelion Pharmaceuticals |
Tracleer |
Cardiovascular |
Woolley Pau |
|
Alliance Pharmaceuticals |
Hydromol |
Dermatology |
RFA Advertising & Marketing |
|
AstraZeneca |
Meronem |
Antibiotics |
GSW Worldwide |
|
British Medical Journal |
Clinical Evidence |
N/A |
The Foundry |
|
Galen |
Calceos |
Calcium supplement |
Dark Horse |
|
Galen |
Miacalcic |
Post-menopausal osteoporosis |
Dark Horse |
|
Galen |
Regurin |
Overactive bladder |
Woolley Pau |
|
Kogen |
Diclomax |
Arthritis and pain |
Swordfish Advertising |
|
Janssen-Cilag |
Multimedia project |
Migraine |
RFA Advertising and Marketing |
|
Novartis |
Diovan/CoDiovan |
Cardiovascular |
ICC (Lowe Healthcare WW) |
|
Nycomed |
New products |
N/A |
Lowe Azure |
|
Pfizer Consumer Healthcare UK |
Media activity |
OTC and POM portfolio |
Medical Media Services |
|
Pliva |
Cystistat |
Interstitial cystitis |
RFA Advertising & Marketing |
|
Sanofi Pasteur MSD |
Childhood vaccines portfolio |
Vaccines |
Swordfish Advertising |
|
Wyeth |
Prevenar |
Vaccines |
Scholz & Friends Life Science |
Share
Related Hub content
Subscribe to our email news alerts
Featured jobs
- Market Access Director, six figure base salary and £5K joining b...
-
Highly competitive salary
- Principal Medical Writer/ Scientific Lead, Medcomms, £5K joining...
-
Highly competitive salary
- Exciting Medical Writer Career Opportunity for Postdoc, Medcomms
-
Highly competitive salary
- Lead Market Access Writer, £5K joining bonus, UK
-
Highly competitive salary
- World Health Organization releases latest set of COVID-19 guidelines
- Europe’s cancer community publishes new report on transforming patient care
- BeiGene’s Brukinsa receives FDA approval for chronic lymphocytic leukaemia
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- Eli Lilly announces $450m investment in US manufacturing site
- EU outlines measures to mitigate antibiotic shortage across Europe
- Innovative Trials comments on extra funding to increase access to clinical trials for cancer patients
- Gilead’s CAR-T cell therapy recommended by NICE for lymphoma
- JCVI recommends autumn COVID-19 vaccine booster for those at highest risk
- MIT researchers develop AI model to detect future lung cancer risk
- Merging global and local pharmacovigilance operations into a successful integrated approach
- Diversifying Healthcare AI with Federated Learning
- FDA and CDC investigate potential safety concern for Pfizer/BioNTech’s COVID-19 vaccine
- World Health Organization releases latest set of COVID-19 guidelines
- AbbVie and Eli Lilly leave UK’s voluntary drug pricing agreement
- AbbVie trial backs chemo-free Imbruvica combo regimen
- AstraZeneca/Daiichi Sankyo’s Enhertu approved by EC for advanced breast cancer
- EU to revise pharmaceuticals law amid antibiotic shortages
PMHub
Research Partnership
Research Partnership, an Inizio Advisory Company, is a world-leading custom and syndicated global insights partner for health and life science...
Latest intelligence
- Virtual Steering Committee & Peer Influence Program
- In this customer story, we describe the methodology and results of our client’s ongoing Virtual Steering Committee & Peer Influence program....
- Meeting healthcare’s rising challenges
- The journey to discover novel therapies through digital innovation and ensure scientific advances achieve their potential...
- Report gives insights to address gaps in HCP engagement
- How does Pharma-HCP engagement need to evolve in today's digital landscape?...
